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Ras proteins serve as crucial signaling modulators in cell proliferation through their ability to 
hydrolyze GTP and exist in a GTP “on” state and GTP “off” state. There are three different 
human Ras isoforms: H-ras, N-ras and K-ras (4A and 4B). Although their sequence identity 
is very high at the catalytic domain, these isoforms differ in their ability to activate different 
effectors and hence different signaling pathways. Much of the previous work on this topic 
has attributed this difference to the hyper variable region of Ras proteins, which contains 
most of the sequence variance among the isoforms and encodes specificity for differential 
distribution in the membrane. However, we hypothesize that sequence variation on lobe II 
of Ras catalytic domain alters dynamics and leads to differential preference for different 
effectors or modulators. In this work, we used all atom molecular dynamics to analyze the 
dynamics in the catalytic domain of H-ras and K-ras. We have also analyzed the dynamics of 
a transforming mutant of H-ras and K-ras and further studied the dynamics of an effector-
selective mutant of H-ras. Collectively we have determined that wild type K-ras is more 
dynamic than H-ras and that the structure of the effector binding loop more closely resembles 
that of the T35S Raf-selective mutant, possibly giving us a new view and insight into the 
v 
 
mode of effector specificity. Furthermore we have determined that specific mutations at the 
same location perturb the conformational equilibrium differently in H-ras and K-ras and that 
an enhanced oncogenic potential may arise from different structural perturbations for each 
point mutation of a specific isoform. 
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Chapter 1  
Introduction 
 
1.1 History of Ras and Biological Function 
RAS genes were initially discovered in rodent viral oncogenes that were capable of inducing 
sarcomas in new-born rodents [1,2]. To date constitutively active Ras mutants have been 
implicated in about 30% of human cancers, and it has been the target of numerous 
biochemical and biological studies in the field of cancer research [3,4].   
Ras proteins (Ras) belong to the Ras Superfamily of GTPases, which function as small 
(21kDa) molecular switches by cycling between an “ON” GTP-bound and “OFF” GDP-
bound conformational states. While members of the Ras superfamily share similarity to 
heterotrimeric G protein α subunits in both their biochemistry and function, they are 
monomeric [5,6]. Ras proteins function as signaling modulators through cell surface 
receptors to activate various effector pathways that control cellular proliferation, 
differentiation, or cell death [6,7].  Ras associates with guanine nucleotides (GTP/GDP) with 
high affinity and possesses intrinsic GTPase activity. The slow GTPase activity of Ras is 
accelerated by binding to specific GTPase activating proteins (GAPs) [8] resulting in an 
inactive state of the protein since  Ras∙GDP has low affinity for effectors [9]. Ras activation 
is then achieved through the association of Ras∙GDP with guanine nucleotide exchange 
factors (GEFs) which displace GDP for the more abundant GTP in the cell [10]. Activated 
Ras then interacts with several downstream effectors including the Raf kinase, 
phosphoinositide 3-kinase γ (PI3K) and RalGDS in response to growth factor stimulation.  
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Figure 1.1 Schematic of Ras signaling in the cell
1
 
1.2 Ras Structure  
Members of the Ras superfamily all possess a G-box or P-loop sequence, which is a signature 
of the purine nucleotide binding motif VAAAAGXXXXGK(S/T), where A is either leucine, 
isoleucine or valine,  and X is any amino acid [11]. On Ras the P-loop consists of amino 
acids 10 to 17. Human Ras proteins consist of four highly homologous isoforms; H-ras, N-ras 
and K-ras (4A and 4B). The Ras protein structure can be divided into two lobes. Lobe I 
(residues 1-80) is 100 % conserved amongst the isoforms. In lobe II (residues 80-160) there 
is ~ 70-80% sequence identity between any pair of vertebrate RAS gene products [12]. 
Together lobes I and II comprise the catalytic domain. The hyper variable region (HVR) is 
composed of the remaining 25/26 amino acids and is highly variable except for the last 4 
residues which are conserved amongst RAS and related genes. These last four residues form 
                                                          
1
 This image was created based on numerous reviews and illustrations of Ras signaling for the purpose of this 
thesis. 
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the CAAX motif, where A is any aliphatic amino acid X is any amino acid [12].  Ras proteins 
undergo differential post-translational modification at the C-terminus, which are crucial for 
membrane binding [13]. Mutations at the CAAX motif abolish Ras signaling and membrane 
localization [14]. Crystallographic and mutagenesis studies have identified the highly flexible 
switch regions as critical for the association of Ras with effectors, GAPs and GEFs 
[15,16,17,18,19].  Switch I includes α helix I and loop 2 (residues 25 - 402) and switch II 
contains loop 4 and α2 (residues 60 - 75). Sequence alignment of human Ras isoforms and 
the related Rap 1B highlights sequence variation between Ras and Rap at lobe II as well as 
the switch regions (Figure 1.2). Rap 1B also associates with the Ras effector Raf at switch I 
[20]. However, whereas Ras activates Raf, Rap has an inhibitory role which can be reversed 
by mutating switch I residues to resemble that of Ras switch I [21].  This emphasizes the 
importance of conservation of lobe I residues amongst Ras isoforms in their ability to 
associate with a shared set of effectors.   
The tertiary structure of Ras isoforms consists of a six-stranded beta sheet and five alpha 
helices connected by 10 loops [22].  Lobe I contains the functionally important switch 
regions which undergo a conformational change upon GTP hydrolysis (Figure 1.3) [23]. A 
magnesium ion is found in the pocket formed by switch I and the P-loop, coordinated by the 
γ-phosphate of GTP and the switch I residue T35. Multiple studies on oncogenic Ras have 
identified positions 12, 13 and 61 [24] as the primary sites where activating somatic 
mutations result in a constitutively active protein characterized by a reduced GAP action 
and/or intrinsic GTPase activity. [8] 
                                                          
2
 Switch I and II have various descriptions on the range of residues however, they both encompass the α-helices 
and loops mentioned. The residues indicated are what we have used to identify switch I and II for this study.  
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Figure 1.2 Sequence alignments of human Ras isoforms and the related protein RAP1B.  
Switch regions are colored in pink and purple with secondary structures indicated at the top, 
colored black for α helices and grey for β strands. Cyan , turquoise, red and yellow highlight 
residues in K-ras 4A , K-ras 4B , N-ras and Rap1A respectively that differ from H-ras in 
sequence. Residues in green highlight the sequence variability of Rap1B on lobe II. 
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Figure 1.3: (a) Superimposition of Ras structures in the active (red) and inactive (green) 
states based on pdb ids 1QRA and 4Q21, respectively. α helices and β sheets are labeled, as 
are residues 12 and 61. GTP and GDP are depicted in licorice. (b) The figure in (a) is rotated 
to highlight differences in the switch II conformation.  
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1.3 Ras Conformational Switching  
Although Ras proteins function by cycling between Ras∙GTP and Ras∙GDP conformational 
states, NMR studies have shown that GTP Ras exists in two major conformational sub-states 
termed state I and state II [25].  State I is assumed to be a weak effector binding 
conformation characterized by the loss of interaction between the GTP γ-phosphate and T35 
OH, which results in a marked displacement of switch I from the nucleotide [26]. Since, the 
interconversion between states I and II is accounted for by the change in interactions of T35 
with Mg
2+
 and T35 with the γ phosphate, mutants of T35, such as T35S and T35A, 
predominantly assume the state I conformation. The former weakly populates state II upon 
addition of effectors [27].  GTP hydrolysis is greatly reduced in state I, however in some 
cases addition of effectors results in a shift to state II and an increase in the GAP-assisted 
GTP hydrolysis rate [25]. Based on these observations one may hypothesize effector binding 
involves a combination of conformational selection and induced fit mechanisms. Further 
studies have shown that both point mutations of the nucleotide (i.e. GTP analogues) can shift 
the conformational equilibrium to state I [28,29,30].  Moreover, Ras∙GDP and state I 
Ras∙GTP have a higher affinity for GEFs whereas state II Ras∙GTP does not interact with 
GEFs [31]. The rate limiting step in Ras conformational switching has been proposed to be 
the dissociation of GDP from Ras by GEFs [32]. Although nucleotide free Ras may be very 
dynamic and unable to associate with modulators or GAPs, a recent study showed that 
nucleotide free Ras interacts with a class II phosphatidylinositol 3-kinase beta in an 
inhibitory manner, which is not observed for Ras∙GTP [31]. Summarizing these observations 
Figure 1.4 illustrates our updated view of Ras conformational cycling.  
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Figure 1.4: Illustration of Ras conformational switching based on pdb ids 1BKD (1)
3
 , 
3KKN (2), 1QRA(3) and 4Q21(4). Switches I and II are in pink and purple, respectively, and 
the nucleotide is shown in yellow. One can clearly see that the switch regions undergo large 
conformational changes, with nucleotide free Ras characterized by wide open switch I/II 
whereas in Ras∙GTP state II the switches are closed over the nucleotide.  
 
1.4 Isoform Specificity and Functional Roles for Ras isoforms. 
Although Ras isoforms have highly conserved catalytic domain and their expression 
ubiquitous and broadly conserved across eukaryotic species, there has been overwhelming 
evidence that their biological activities are not redundant. Firstly, H-ras and N-Ras have been 
shown to be dispensable for development in mice, whereas K-ras 4B (from here on K-ras) 
knockout results in embryonic lethality. Moreover, these studies revealed that K-ras is 
sufficient for development in the absence of H-ras and N-ras [33,34]. Besides the critical role 
                                                          
3
 Labeled on the diagram for easier reference 
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of K-ras for development, H-ras and K-ras differ in their ability to activate different effector 
pathways including the Rac, Raf and PI3K pathways [35,36,37]. Additionally, the tumor 
suppressor and Ras effector RASSF5/NORE-1 and RASSF2 bind strongly to K-Ras but only 
weakly to N-Ras and H-Ras [38,39]. Finally calmodulin modulates K-ras∙GTP function but 
not H-ras or N-ras [40]. 
Role of the HVR in Isoform Specificity 
Much of the previous work on Ras isoform specific signaling have focused on the role of the 
HVR and its differential posttranslational lipid modification, and the resultant effect on 
membrane localization and effector recruitment [13,41,42]. Consequently, the majority of 
investigations into Ras isoform specific signaling have focused on Ras nanoclustering and 
distribution on membrane domains. Indeed, analysis of Ras micro-localization in the 
membrane shows that activated H-ras and K-ras reside in non-overlapping cholesterol–
independent domains stabilized by galectin 1 for H-ras and galectin 3 for K-ras whereas 
inactive H-Ras localizes to cholesterol-dependent domains [13,43,44]. Additionally, Raf-1 is 
preferentially recruited to K-Ras-GTP nanoclusters and retained in these clusters but not 
retained in H-ras nanoclusters [42].  
Is there a role for specific conformational dynamics at the catalytic domain? 
While there is substantial evidence that clearly shows the role of Ras localization and 
orientation in the membrane to explain isoform specific signaling, the possible role of 
isoform specific dynamics at the catalytic domain has not been well studied. Furthermore, 
there is a growing body of evidence that suggests a role for isoform specific dynamics of K-
ras and H-ras in modulating function. Moreover, previous biochemical and mutational 
9 
 
studies have shown that the catalytic domain may play a role in specificity towards effectors 
[37,45].  Firstly H-ras has been shown to bind Raf-RBD with slightly higher affinity than K-
ras [46]. Meanwhile, in vitro biochemical studies revealed that these isoforms exhibit 
specificities in their ability to activate different effector pathways, with K-ras being a more 
potent activator of Raf independent of Raf-recruitment to the membrane, while H-ras is a 
more potent activator of PI3K [37]. Also, specific H-ras mutations are capable of shifting the 
specificity towards specific effectors (Table 1.1) [47]. Moreover, the Ras GEF Ras-GRF 
activates H-ras but not N-ras or K-ras 4B and that palmitylation was not required for the 
specificity of Ras-GRF to H-ras [48].   
Isoform specificity in diseases 
Genetic studies revealed that the occurrence of Ras mutations in tumors are isoform specific, 
with K-ras being the most frequently mutated isoform in in pancreatic, colon and lung cancer 
whereas H-ras has a higher occurrence in bladder carcinomas and N-ras in neurological 
cancers [49]. Surprisingly, also the location of mutations on a specific isoform varies in 
frequency and tissues it is expressed in [50]. For example, oncogenic G12V substitution 
accounts for over 80%  of K-ras mutations, almost double that of N-ras mutations at position 
12. There is a relatively low occurrence of Q61 mutations in K-ras yet H-ras and N-ras are 
found mutated more than 40% and 60% at position 61, respectively. In addition, specific 
point mutations in K-ras may affect effector specificity since more recent studies have shown 
that the oncogenic potential of K-ras G12D in pancreatic tumors is through activation of the 
PI3K pathway rather than C-Raf [51]. Another study revealed that G12D K-ras bound to Raf 
was only about 2% of the total K-ras [52]. Recently, Ras mutants have also been found in 
developmental diseases that share the characteristic phenotype of a group of diseases known 
10 
 
as Neuro-Cardio-Facio-Cutaneos Syndromes (NCFC’s) [53,54]. Within this class of diseases, 
germ line H-ras mutations at position 12
4
 are consistent with the phenotype of Costello 
syndrome, whereas widespread expression of oncogenic K-ras G12D is not tolerated and 
results in embryonic lethality [50,55,56]. Furthermore, K-ras mutants are not found in 
Costello syndrome but appear in other NCFC’s. 
H-ras mutant Location Specific effector
5
 
G12V/T35S 
T35S 
Switch I Raf 
G12V/D38E Switch I Raf 
G12V/D37G Switch I Ral 
G12V/Y64G Switch II Raf/Ral-GDS 
G12V/Y40C Switch I PI3K 
 
Table 1.1: Ras effector specific mutants 
 
Motivation and Specific Aims of This study 
Conformational selection postulates that proteins exist in many different conformational 
states around the average structure [57]. At equilibrium, the conformational states that are 
populated when bound to a particular ligand are part of a conformational repository in the 
absence of the ligand [58]. In the case of Ras, accelerated molecular dynamics simulation and 
other studies have revealed that, in the absence of GTP or GDP, H-ras can sample structures 
that resemble the GDP and GTP state conformations [59]. Moreover, GDP Ras is able to 
associate with a mutant Raf RBD but X-ray analysis of the complex shows a conformation 
                                                          
4
 G12S mutation is the most common; G12V, G12D and G12A were also reported.  
5
 Effector specific mutant ras maintains the ability to associate with only these effectors  
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similar to that of Ras∙GTP [60]. Though GDP∙Ras binds Raf with a much lower affinity than 
GTP∙Ras, this finding clearly demonstrates that in each of the major sub-states there exist 
conformations that can be selected for association with ligands or effectors
6
. The specificity 
of the Ras mutants T35S and Y40C towards interactions with Raf and PI3K further suggests 
that there must be distinct conformational populations in these mutants that favor interaction 
with a specific effector. Since neither residue 35 or 40 have been implicated in direct 
interaction with PI3K or Raf RBD, one may surmise that these mutations alter dynamics 
instead [15,61]. This is true for Y40C H-ras, which, although PI3K specific, can still 
associate with Raf under very high (non-physiological) concentrations of Raf RBD [28].  In 
this work, we aim to assess the dynamics of Ras in the GTP bound state to probe specific 
dynamical and conformational differences between H- and K-ras isoforms and between wild 
type mutant Ras proteins. The first specific aim of the study is therefore a detailed 
investigation of Ras dynamics through all-atom molecular dynamics simulations of the 
catalytic domain. The second aim is to assess the specific role of conformational dynamics 
and residue interactions within each sub-state and how these might be affected by point 
mutations. Our overreaching hypothesis is that sequence variation on lobe II (Figure 1.5) 
of Ras alters dynamics and leads to differential preference for different effectors or 
modulators.  
                                                          
6
 The Raf A89K mutant was used in the mentioned study because of its higher affinity for Ras. 
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Figure 1.5: Cartoon representation of H-ras catalytic domain (pdb 1QRA) with the locations 
of sequence variation between H-ras and K-ras colored in blue and labeled in orange for H-
ras and blue for K-ras. 
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CHAPTER 2 
 
Overview of Molecular Dynamics Simulations and Key Trajectory Analysis Techniques 
 
In order to examine the various conformational states of Ras proteins we have utilized 
molecular dynamics (MD) simulations to produce an ensemble of structures (conformers). A 
comprehensive analysis of the MD-derived trajectories was carried out utilizing several 
analysis techniques.  In this Chapter, I will provide the reader with a general overview of the 
theoretical basis of molecular dynamics simulations as well as principal component analysis 
(PCA) and other multivariate data analysis techniques used to characterize Ras dynamics and 
structural perturbations.   
 
2.1 Molecular Dynamics  
Molecular dynamics is a computational method that is used to describe the motions of atoms 
and molecules. MD relies on concepts from statistical mechanics and thermodynamics to 
study biomolecular dynamics at the atomistic level, and is used to observe global (large-
scale) fluctuations as well as local motions and specific effects of external perturbation of 
protein conformations.  In an MD simulation, each atom is considered to be a point mass and 
its motion is determined by the forces exerted upon it by all other atoms as determined by 
Newton’s equations of motion in classical dynamics [62,63]. MD allows us to explore the 
dynamics of proteins in silico on timescales inaccessible to conventional in vitro or in vivo 
methods.  
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Generating an MD trajectory 
In order to generate a MD trajectory starting atomic coordinates from X-ray crystallography, 
NMR or homology modeling, as well as assignment of random atomic velocities are needed. 
Newton’s equation describes the force Fi acting on particle i in terms of the product of the 
mass (m) and acceleration (a) of the atom: 
                                                                  Fi = miai                                                                                (2.1) 
Force can be described as a gradient of the potential energy (V) ,     
                                                                                     (2.2) 
and the derivative of the potential energy is related to the change in atomic position as 
                              
  
   
   
    
   
 .                                                      (2.3) 
Acceleration is therefore as the derivative of the potential energy with respect to position, r. 
In an MD simulation, the protein is described as a series of charged points (atoms) linked by 
springs (bonds). At each step during the simulation, the forces on each atom are computed 
and the atomic position and velocity are updated according to Newton’s laws of motion. 
These forces are determined from the force field, which is a collection of parameters that 
represent both bonded and non-bonded energy terms [64]. 
A typical force field has the following functional form: 
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The first three terms represent the bonded energy terms defined oscillations about the 
equilibrium bond length, angle and torsion, while the last two terms represent the non-
bonded energy terms described by the Lennard-Jones potential and the Coulomb equation. 
The Lennard-Jones potential is weakly attractive at short distances for two uncharged 
molecules, but is strongly repulsive when they approach too close. The Coulomb potential 
describes the interaction between two point charges. Using the relationship         , the 
forces acting on the atoms are calculated and the atomic positions can be updated through the 
numerical integration of Fi = miai. 
An major advantage of MD over other methods is that it is one of the most detailed 
molecular simulation methods which computes motion of individual atoms [65]. The 
limitations include the limited size of conformational space that can be sampled and the 
accuracy of the force field. The problem of sampling limitation is the most severe and is 
coupled with the size and complexity of the system to be simulated. This sampling issue is  
currently being addressed by several computational groups [66].  
The  use of an integrator scheme such as Leapfrog or the Velocity Verlet algorithms assumes 
the positions, velocities and accelerations can be approximated by a Taylor series expansion. 
NAMD uses the Velocity Verlet to advance the positions and velocities of the atoms in time, 
which computes the forces of the atom as a function of position, and does not involve the 
explicit calculation of the velocities [67]. Additionally in order to reduce the cost of 
evaluating the forces due to long range electrostatics, NAMD utilizes a multiple time-
stepping scheme.  Through the use of specific cutoff distance, the forces on local and  long 
range electrostatic interactions within the cutoff is computed while long range interactions 
beyond the cut-off are computed less often  
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Periodic boundary conditions are a method of simulating many atom systems and improving 
computational efficiency by eliminating the behaviors near the walls of the system. The bulk 
of the system is assumed to be composed of the primary cell which is surrounded by its 
mirror image on all sides. Utilizing periodic boundary conditions allows any atom that leaves 
a simulation box from one side to enter from the other since molecules are free to diffuse 
within the system [68].   
 
2.2 Analysis of Molecular Dynamics Trajectories 
In order to correlate the functional relationship with the structure it is imperative that we 
study the dynamics which is correlated with conformational changes and flexibility crucial 
for protein function.  
A variety of analyses were performed on the resulting molecular dynamics trajectory using 
the programs VMD [69], Bio3d in R [70] and Wordom [71]. The first step involved removal 
of the waters and alignment of the Cα coordinates of the atoms to the core atoms of the 
protein  using the Kabsch algorithm [72], which computes the rotation matrix that minimizes  
the RMSD. Alignment of the structures is necessary to remove translational motions inside 
the simulation box as the protein is free to diffuse.  
Root Mean Square Deviation analysis (RMSD) 
Root mean square deviation (RMSD) is used as a measure of the difference between two sets 
of values. Here the RMSD of each atom is computed with respect to a reference structure, 
over the time course of the simulation. In this way the RMSD can give valuable information 
about the extent of the conformational difference between two structures. Furthermore a plot 
of the RMSD of a trajectory is useful to gauge equilibration of the system or to identify the 
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time points of conformational changes for further analysis. In our RMSD analysis, each 
frame of the trajectory was first fitted on a reference structure based on the core atomic 
coordinates to remove translation and rotation of the protein. Since RMSD is dependent on 
the atoms used for fitting and for our purposes only Cα atoms were used as a representation 
of the protein backbone. 
                                         √
 
 
∑ |                 |                                           (2.5) 
 
In equation 2.5, N is the total number of atoms and xi(t1) is the position (x) of atom i at time 
t1 and xi(ref) is the reference  position.  
Root Mean Square Fluctuation (RMSF) 
While crystal structures provide valuable information about the average structure of a 
protein, MD simulations allow us to investigate the dynamic fluctuations around the average 
structure. While the the RMSD is a way of identifying the fluctuations of different 
conformers over time, the RMSF serves as a means of describing the individual atomic 
fluctuations. 
The mean square fluctuation gives the deviation of each atom (Cα most widely used) 
averaged over time. This is similar to the B-factor in crystallographic studies, which attempts 
to show the dynamics of individual atoms. The RMSF of atomic positions is measured from 
the structure . Flexibility is of great importance to a protein’s biological functioning, stability, 
and conformational behavior directly affecting the conformational changes within the time 
period sampled.  The RMSF is given as  
                                                        √
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Dynamic Cross Correlation (DCC) Analysis: 
Dynamic cross correlation is a useful method to capture and characterize correlated atomic 
motions, thereby defining long-range allosteric couplings within a protein. The theory behind 
DCC lies in the fact that residues of a domain (or region) move in concert with one another 
based on their atomic cross correlation coefficients. These correlation coefficients are 
determined from the positional vectors.  In analyzing time covariance and the normalized 
covariance or cross correlations of atomic fluctuations, we can gather information about the 
correlated atomic motions [73]. For the displacement vectors of atoms i and j (Δri and Δrj), 
the covariance c(ij) is given by the dot product of the ensemble average < > of these 
displacements. 
                                              c(ij) = <Δri ·Δrj>                                                               (2.7) 
The mean square atomic fluctuation <Δr2i
 > is the diagonal of <Δri·Δrj> .The normalized 
covariance,       is the cross correlation of …… and is given by: 
                                               
               
    
         
     
                                                         (2.8) 
In a molecular dynamics trajectory the covariance is computed over time by estimating the 
ensemble average over a set of discrete time points for a pair of atoms i and j.  In the current 
study we employ dynamic cross correlation analysis to identify the communication pathways 
across Ras isoforms and mutants. 
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Principal Component Analysis (PCA)  
MD essentially yields multivariate data set, where many of the variables (atomic coordinates) 
are correlated or dependent on each other. A multivariate analysis tool is needed to 
investigate the most relevant collective fluctuations. One such technique that has gained 
popularity in analyzing protein trajectory data is Principal Component Analysis (PCA), 
which reduces a multidimensional data set to a lower dimensional data. In applying PCA to 
molecular dynamics trajectories the goal is to reduce the data such that it highlights the 
independent variables (atomic coordinates) to explain the conformational changes of interest. 
In some instances it is also useful to apply PCA using dihedral angles instead of atomic 
coordinates, however a transformation from angular coordinates to ϕn to Cartesian coordinate 
space {xn=cosϕ n , yn=sin ϕn } must be performed [74]. 
The application of PCA involves first the diagonalization of the covariance matrix of atomic 
positions and then identification of an orthogonal set of eig envectors, which describe the 
direction of maximum variation in the data set. The eigenvectors of the covariance matrix are 
the axes of maximum variance.  The principal components (PC’s) are dot products of the 
original variables with a weight α that are uncorrelated and ordered such that the first few 
PC’s retain the greatest percentage of the variance that was present in the original variables. 
To reiterate this concept,  we can consider an example of a vector x with p random variables. 
A linear α'1x function of the elements of x that has maximum variance where α1   is a vector 
of p constants 
                                          Z1=   α11x1 + α12x2 + … + α1pxp=∑      
 
                                                (2.9)      
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 The weights in this case are the eigenvectors of the covariance matrix, and are interpreted to 
reveal the per-residue contribution to the variance (Figure 3.2) .The second PC (z2 = α'2x) 
has the properties of having the second highest variance but is uncorrelated with z1. This lack 
of correlation between the PCs is very important in interpreting the data since the indices of 
the PC’s can be interpreted as variance in different dimensions in the original data. The 
original data is then projected onto the weights (α) of the associated principal components 
and these are plotted against each other.  
2.3. Salt bridges, Hydrogen Bonds and Hydrophobic Contacts 
A contact map was made to select residue-residue contacts based on an inter-atomic distance 
cutoff of 4 Å between the side chains of atoms. The 4 Å distance cutoff is sufficient to 
identify atomics interactions that may be electrostatic and hydrophobic interactions between 
residues. After the initial conformer analysis, we utilized this map to identify unique residue 
– residue contacts for each system.  Hydrogen bonds (H-bonds) exist between a polar H atom 
(such the amide hydrogen, NH) and an unshared pair of electrons in an electronegative atom 
such as oxygen and nitrogen.  For instance, since an amide N atom is electronegative the H 
on the NH atom becomes partially positive or has a positive dipole this atom is then attracted 
to another electronegative atom such as an O or N with an unshared pair of electrons. The 
energy of a H-bond can be up to 4-13 kJ mol
-1 
[75]. Therefore, hydrogen bonds contribute 
greatly to the overall stability of proteins [76]. To identify H-bonds of interest we used the 
VMD H-bond plugin which identifies H-bonds based on a donor-acceptor distance cutoff of 
3.0 Angstrom and a donor-H-acceptor angle cutoff of 20.0 degrees (Figure 2.1).  
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Figure 2.1: Illustration of the hydrogen bond (H-bond) criteria used. A distance of less than 
3Å between the donor (D) and acceptor (A). The angle θ is less than 20 degrees since the H- 
bond is almost linear and ω is less than 180 degrees.  
 
Salt bridges are formed by the electrostatic interaction between oppositely charged amino 
acids mainly Aspartate and Glutamate with Lysine and Arginine, when they come within a 
certain distance to experience an electrostatic attraction.  They have been shown to play 
important roles in protein function including molecular recognition, allosteric regulation, 
flexibility and thermostability [77]. The roles of salt bridges in protein stability have been a 
widely debated issue. Mutational studies aimed at disrupting salt bridges in proteins have 
indicated that they actually contribute less to protein stability but instead have greater 
contributions to the burial of hydrophobic side-chains to form and stabilize the core. 
However studies on surface salt bridges have revealed that altering certain salt bridges can 
have a substantial effect on protein stability, with a possible advantage to promote protein 
stability at higher temperatures [78,79]. Salt bridges have been found to play critical roles in 
conformational changes.  For example, rhodopsin cycling between inactive and active states 
involves the formation and breakage of a salt bridge between two helices [80].  
In our systems we used a distance cutoff of 3.2 Å between the side chains of either oxygen of 
acidic amino acids and the nitrogen of basic residues to define a salt bridge. Figure 2.2 
illustrates a salt bridge formed between K5 and D54 in the Ras crystal structure. This salt 
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bridge may a have functional role since mutations of the K5 residue to N have been 
implicated in colon cancer and developmental diseases. [81,82] 
 
 
Figure 2.2: Salt bridge formed between two β strands on H-ras (pdb 1QRA). Nitrogen and 
Oxygen atoms involved in the salt bridge are labeled as N and O respectively 
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CHAPTER 3 
 METHODS 
Chapter Overview: 
In this Chapter I will present details of the methods used to assess the conformational 
dynamics across Ras structures and conformers obtained from molecular dynamics 
simulations. Firstly an overview of the simulation details will be presented, followed by 
Principal Component Analysis (PCA) that was used to explore the various conformational 
states of Ras crystal structures
7
 in the nucleotide bound state and in complex with 
effectors/modulators. I will then discuss the application of PCA to analyze the MD 
trajectories and expound on the clustering analysis used to detect major conformational 
clusters for a detailed analysis. Lastly a brief definition of the parameters used to characterize 
the conformational states of Ras obtained from MD simulations is presented.  
3.1 Molecular Dynamics Simulations of Ras. 
Rationale 
In order to identify different conformational states for H-ras and K-ras, MD simulations were 
carried out on the catalytic domain (residues 1-166 or 1- 167) of these isoforms, with bound 
GTP and Mg
2+
. NMR analysis of full length H-ras have reported that the biochemical 
properties of the protein are retained in the truncated protein that possesses just the catalytic-
domain, hence analysis of the catalytic-domain is sufficient to explore Ras dynamics that 
may perturb its function [83].   
The H-ras T35S mutant (T35S) was also studied because it retains the ability to associate 
with Raf but not PI3K [84].  Specifically, through analysis of T35S and a comparison with 
H-ras and K-ras we hope to either gain insights into Ras dynamics that may favor interaction 
                                                          
7
 Obtained from the PDB data bank. 
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with Raf or interfere with its association with PI3K. We included the T35A H-ras mutant 
(T35A) because it predominantly exists in state I and does not interact with any known 
effectors of Ras, hence the conformations sampled by this mutant will be considered non-
favorable for effector/GAP interactions [26].  
Crystal structures of Q61H H-ras and K-ras oncogenic mutants in complex with GNP
8
 and 
Mg
2+
 were retrieved from the PDB data bank. These simulations were run to satisfy two 
requirements. 
1. Validate the structural differences between H-ras and K-ras since no WT K-ras 
structure is currently available. 
2.  To answer the question: Do specific mutations perturb the conformational dynamics 
of Ras isoforms differently?  
Simulation Details 
Production simulations were commenced after equilibration and minimization of the 
coordinates of the appropriate crystal structures from the Protein Data Bank (PDB)[85]. The 
details of each system are listed in Table 3.1, along with corresponding mutations and 
starting structures. Missing hydrogens were built and the protein structure file was created 
using the psfgen plugin within VMD [69]. The systems were prepared by first solvating the 
protein in a water box of padding 10 Å around the molecule and a cubic box of dimensions 
60.43 x 60.43 x 60.43Å
3
 . Crystal waters were retained and the systems were checked to 
remove water clashes (i e. waters within 2.4 Å of the protein) and subsequently neutralized 
by the addition of Na
+
 and Cl
-
 ions. Histidine residues were set to neutral.  
                                                          
8
 The GNP was replaced with GTP in simulations. 
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The resulting systems were subjected to energy minimization with a time step of 1fs using 
the conjugate gradient method, which consisted of 2000 steps with harmonic restraints placed 
on the heavy atoms (k = 4 kcal/mol/Å
2
) and another 2000 steps with the harmonic restraints 
turned off. The minimized systems were then slowly heated to a temperature of 310K in 
50000 steps, and finally equilibrated with constraints of 4.0 kcal/mol/Å
2 applied to the 
backbone atoms, which was subsequently decreased 25% in four steps to 0 over 0.7ns.   
After initial energy minimization and equilibration, production simulations were performed 
at constant temperature (310K) and pressure (1atm) with a 2fs time step using the NAMD 
engine [86] and CHARMM27 force field [87]. The SHAKE [88] algorithm was employed to 
constrain bonds involving hydrogen atoms.  
Trajectories were written out every picosecond. Periodic boundary conditions with full 
Particle-Mesh Ewald (PME) electrostatics [89] were used with  a non-bonded cutoff of 8.5Å 
and 10Å for non-bonded list update. Each simulation was run for at least 400ns, which is 
sufficient to examine collective motions including hinge bending, which occurs on the 10
-11
s 
to 10
-7
s time scale, and loop motions that occur on the 10
-9
 to 10
-5
s  time scale [90,91]. The 
total simulation time was 2.9 µs. 
Analysis of the trajectories was carried out using a combination of scripts prepared for Bio3d 
[70]  in R [92], Wordom [71], and VMD. Prior to subsequent analysis all systems were 
stripped of waters. For PCA and DCCM analysis only Cα atoms were used for analysis and 
conformers were sampled every 0.1ns. 
 
 
 
26 
 
Simulation 
name 
Simulation 
length (ns) 
PDB id of 
Starting 
Structure 
Resolution 
(Å) 
Modification Residue Ligand 
H-ras 550 1QRA 1.6 - 1-166 GTP Mg
2+
 
K-ras 600 3GFT 2.27 H61 Q 
GNP GTP 
1-167 GTP Mg
2+
 
Q61H (H) 350 6Q21 2.4 GNP  GTP 1-166 GTP Mg2+ 
Q61H (K) 400 3GFT 2.27 GNP  GTP 1-167 GTP Mg2+ 
T35S (H) 550 1XCM 2.09 GNP  GTP 1-166 GTP Mg2+ 
T35A (H) 400 1QRA 1.6 T35 A 1-166 GTP Mg2+ 
                   Total of 2.9 ns 
Table 3.1: Simulation Details 
3.2 PCA of Ras x-ray structures 
Principal component analysis (described in Chapter 2) is a useful tool for visualizing and 
classifying protein conformers [93]. However, before PCA can be applied one needs to 
reduce the number of variables or the structural complexity in order to achieve meaningful 
results. Therefore, we performed PCA only on the Cα co-ordinates of residues 1-164.  To 
study the various conformational states of Ras, X-ray structures were chosen from the protein 
data bank including all Ras-GTP
9
/GDP structures deposited to date. Structures that were 
missing residues within residues 1-164 were omitted and the remaining 65 structures were 
used to create a conformer plot. All structures were aligned to 3GFT chain A based on the Cα 
coordinates of the core residues reported by Gorfe et al. in 2008 [94]. A PC plot illustrates 
conformers in terms of their displacement along a particular PC, which reflects the variance 
at the residues that contribute to the particular PC.  Additionally a plot of the PCA loadings 
describes specific residue contributions to the displacements in the PCs.  Hence we can 
                                                          
9
 Structures that are crystalized with GTP analogues are also selected and in some cases effectors and small 
Molecules. The Mg
2+
 ion is present in many structures. 
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gauge the conformational differences due to residues that contribute significantly to the 
variance along particular PCs. In this way PCA and a plot of conformations provides an 
efficient method of identifying different conformational states.   
PC vs RMSD clustering 
Both PCA and RMSD are useful tools for identifying conformational differences. Hence we 
can use a difference matrix composed of the pairwise RMSD or significant PC’s for distance 
based clustering. The advantage of PCA in this case is that it allows the identification of 
critical domains or residues that are important for functional conformational switching. One 
can easily visualize the different conformational clusters of Ras as a function of 
conformational similarity at specific regions.  The PC plot (Figure 3.1) clearly defines Ras 
conformational states along PC1 and PC2. These results are in agreement with PCA of Ras 
reported in Gorfe et Al (2008) [94], however state I conformers had not been included in the 
previous data set. In Figure 3.1 structures that represent state I conformations (blue), state II 
(red and orange) and Ras∙GDP (green). Cluster selections based on either RMSD or the first 
three PC’s are able to clearly identify these different conformational states. A dendrogram of 
the crystal structures serves to further illustrate the hierarchal clustering based on RMSD 
differences (Figure 3.3). The two most conformationally different structures are 3KKN and 
2Q21. Also highlighted are T35S H-Ras (3KKN) where there is a significant perturbation at 
switch I and switch II, as well as the G12V H-ras (2Q21) with distorted switch II (Figure 
3.1). 
PC-based clustering is able to highlight conformational differences in the switch regions as 
well as other regions of high variance (Figure 3.3).  For example, H-ras in complex with 
caged GTP (CAG), pdb 1GNQ, is assigned to a separate cluster based on the PCs due to 
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significant conformational changes in switch I. Also the structure of 3KUD (Ras∙GDP-Raf 
complex) is almost identical to WT H-Ras at switch I but differs at switch II and helix III.  
 
Figure 3.1 A PCA map of 65 Ras crystal structures colored by RMSD-based clusters. 
Proteins in colored cartoon representation are representative crystal structures of each cluster 
colored according to their cluster and aligned against WT H-ras (orange). These structures 
are labeled by their PDB ID and their difference in RMSD from H-ras GTP (pdb 1QRA) is 
reported in Table 3.1. Ras state II clusters are colored orange and pink, State I colored blue, 
GDP and GDP/GTP intermediates green and black respectively.  
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PDB ID STRUCTURE 
INFORMATION 
Δ RMSD from 
1QRA (Å) 
3GFT K-ras∙GNP Q61H 1.03 
3KUD H-RAS∙GDP-RAF 
COMPLEX(DISTAL 
SITE) 
0.82 
4Q21 H-ras GDP 1.67 
2Q21 H-ras G12V∙GDP 1.58 
3KKN                                       H-ras T35S∙ GNP 2.45 
 
Table 3.2: The difference in RMSD of the Cα atoms (1-66) from H-ras∙GTP (Mg2+) 1QRA  
 
 
Figure 3.2: A dendrogram of Ras crystal structures grouped according to RMSD clusters. 
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Figure 3.3: Conformer plots of Ras crystal structures colored according to PC clusters (a-b). 
(c) PCA loadings describing residue contributions to each PC. (d) Scree plot showing the 
contribution of each PC to the total variance. 
 
The PC plot shows a clear distribution of conformational clusters along the major PC’s 1, 2 
and 3 (Figure 3.3), which account for over 75 % of the variance in the data.  The plot of 
residue contributions to the PCs highlights the switches I and II as the major contributors to 
the variance (Figure 3.3 (b)).  H-ras G60A (1XCM) represents a state I conformation. We can 
appreciate the separation from the major GTP cluster mainly due to PC1 because of the 
strong contribution of switch I residues to the variance. Likewise Ras∙GDP (4Q21) is 
separated from the major GTP cluster due to the different orientation of switch II.  
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PCA highlights the structural variance of switch I and switch II among sub-states.  
Switch I and II are known to be the most functionally flexible regions in the catalytic domain 
of Ras. As a result there is a large difference in these regions between state I GTP Ras and 
Ras∙GDP on the one hand and state II GTP Ras on the other. Switch II has a more significant 
role in determining the variance along PC3. This is emphasized in Figure 3.3 (b), where the 
plot of PC2 vs PC3 highlights conformational difference of switch II in GDP intermediate 
structures 2Q21 and 1Q21. Ras∙GTP state II conformers are also very well separated along 
PC’s 2 and 3, highlighting a possible role of this region in conformational diversity within 
state II.  Since switch II undergoes a major conformational change upon GTP hydrolysis 
[23,95], the clear separation of the 2Q21/1Q21 GDP intermediates from the GDP cluster 
further illustrates the importance of switch II flexibility in Ras conformational switching 
between GDP “off” state and GTP “on” state, and the impairment of hydrolysis in Ras 
mutations at the switch regions or P-loop [96]. 
3.3 Selection of Conformational Clusters 
To define the similarity between MD conformers, we applied PCA to each trajectory and 
then performed hierarchical clustering based on a difference matrix created from the first 4 
PCs. The number of clusters based on the elbow in the scree plot (Figure 3.4) [97]. This 
elbow represents the number of PC’s that have significant individual contributions to the 
variance in the data. Significant clusters were chosen to reflect where the contribution of 
each PC is drastically reduced. In Figure 3.3, after the first four PCs (the elbow), the 
contribution of each PC to the variance is less than 3.5%. Therefore for H-Ras a total of 9 
clusters was representing greater than 10% of the total number of simulated conformers was 
selected for further analysis. Table 3.3 lists the details of the clusters and cluster population.  
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Figure 3.4: Scree plot of PCA applied to H-ras conformers. The red line shows the number 
of PC’s used to create the dissimilarity matrix for clustering and the blue line represent the 
number of clusters. 
 
System % Population  
Protein Cluster 1 Cluster 2 Cluster 3 All other clusters 
H-ras 56% 35% 4% 5% 
K-ras 50% 16% 7% 27% 
T35S 28% 16% 13% 43% 
T35A 46% 35% 6.9% 12.1% 
Q61H-Hras 41% 33% 19% 7% 
Q61H-Kras 69% 17% 7% 7% 
 
Table 3.3: Conformational Cluster Population Details. Only the first 3 clusters are shown. 
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3.4. Identification and characterization of Ras Conformational States 
As discussed in Chapter 1, Ras can adopt two major conformational states when in complex 
with GTP, a non-effector binding state I and an effector binding state II. Solution NMR 
analysis of the T35S partial loss of function mutant has shown that the mutant becomes a 
weak effector binder upon addition of effectors. This is true for other state I mutants except 
T35A. Previous solution NMR studies have characterized state I and II based on differences 
in chemical shift values of the β and γ phosphate due to the distance of the phosphate group 
from the aromatic ring of Y32 [25].  Furthermore the chemical shifts associated with the  γ-
phosphate is accounted for in part by a loss of  coordination of the Mg
2+
 ion with the OH of 
T35, since the electronegative environment surrounding the γ-phosphate of the GTP can 
influence the State I/II population [25,29,98]. Hence the loss of the OH of the side chain T35 
in the T35S and T35A mutant results in a population shift to state I. [26]. Consequently we 
utilized the distance between Cα atoms of T35 and G12 10 as well as Y32 and G12 as a 
metric to discriminate conformations that may be considered state I and state II. Figure 3.3.1 
illustrates the position of residues 35 and 32 with respect to their backbone in a state I and 
state II conformation. The Cα distances used for analysis are indicated by dotted lines. To 
assess the conformational space and dynamics of state I conformers we have studied the 
T35A [26,29].  
                                                          
10
 S35 or A35 for T35 mutants 
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Figure 3.5: Orientation of residues 35 and 32 in state II (orange) pdb 1QRA and state I pdb 
3KKN. 
 
3.4 Cluster selection of MD conformers 
Based on the scree plot obtained for PCA carried out on each individual trajectory we have 
utilized the first four principal components to derive our clusters for subsequent analysis. A 
distance matrix was created by utilizing the first four principal components which based on 
the scree plot (Figure 3.4) and also on the pairwise RMSD distances. By utilizing the RMSD 
clusters, which in most cases encompasses more than 1 PC cluster we are able to identify 
dynamic elements that would probably assist in the transitioning between different 
conformations while in the GTP state II state.  
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CHAPTER 4 
 
 Results and Discussion: Ras Dynamics 
 
Introduction: 
Ras proteins influence many different signaling cascades through their interaction with 
various effectors and modulators. However, individual Ras effectors are very different 
proteins although they share a common motif: the Ras Binding (RB) or Ras Association (RA) 
domain. RB encodes the specificity for Ras interaction within a few key residues in these 
domains [99]. The ability of Ras to associate with different effectors and modulators suggests 
that it adopts various conformational states, which have been well studied using X-ray and 
NMR.  However, due to a preconceived notion that H-ras and K-ras were identical in their 
biological properties, much of the previous biological and biochemical assays were done on 
H-ras [45]. Recent studies described in Chapter 1 reveal that there are levels of specificity 
amongst Ras isoforms for different effectors and modulators. Moreover the specificity of the 
H-ras mutants Y40C and T35S to the effectors PI3K and Raf respectively suggests that this 
may be due to changes in the allosteric behavior of the proteins since neither of these 
residues are directly involved in association with either effector. Also studies have shown 
that K-ras and H-ras display a degree of specificity in activating the effectors Raf and PI3K, 
this was found to be not limited to their difference at the HVR and/or membrane localization 
[37]. Furthermore the occurrence of Ras genes in human cancers reveals that isoform 
specificity plays both a role in frequency of a particular isoform and the specific point 
mutation in various cancers [50]. Taken together the effector specificity of H-ras and K-ras 
towards the major effectors PI3K and Raf, coupled with the isoform specific frequency and 
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localization in specific cancers further highlights the need for a detailed analysis of the 
differential dynamics between these isoforms.  
In order to study the specific dynamics of Ras isoforms or to understand the ability of Ras 
interaction with various effectors and modulators we must first consider the role of 
conformational selection in Ras function.  The central postulate of conformational selection 
is that all protein conformations pre-exist and that the most favored conformation is selected 
by the ligand, resulting in a shift and a redistribution of conformational states following 
ligand binding. Subsequent to the population shift an induced fit mechanism may optimize 
side chain and backbone interactions [100]. In this Chapter I investigate the dynamics of Ras 
in distinct conformational states.  Firstly I will compare the overall dynamics of H-ras and K-
ras though PCA. Then the dynamics of specific conformational clusters of H-ras and K-ras 
(described in Chapter 3) is compared to those of T35 H-ras mutants. These MD conformers 
are then related to the conformations of the crystal structures of nucleotide bound Ras 
through PC projection. Lastly I analyze the conformational dynamics of the Q61H mutants. 
The selection and analysis of conformational clusters described here are a fundamental step 
in accessing the dynamics of Ras∙GTP. All of the analysis in this Chapter is based on the 
backbone, which is represented by the C-α atoms details of the atomic interactions within 
each substate of each protein will be addressed in Chapter 5.  
4.1 Increased inter-lobe correlated motions in H-ras relative to K-ras. 
To investigate the overall dynamics of our systems we applied PCA to the entire trajectory of 
each system. The contribution of specific residues to the PC’s differs significantly for H-ras 
and K-ras, especially at switch I and some loops on lobe II (Figure 4.1). The variance 
represented here is indicative of the dynamics where a high contribution to the PC represents 
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a very dynamic region.  These dynamics captured by the first 3 PC’s, which accounts for 
~50% of the total variability of the data in our systems (see Figure 3.4), reveals that there are 
significant conformational differences between the two isoforms. Overall, K-ras is more 
flexible than H-ras at switch I whereas H-Ras is more dynamic at loop regions in lobe II.  
 
 
   
Figure 4.1: PCA loadings or contributions of each residue (Cα coordinates) to the variance 
over all conformations of H-ras(a) and K-ras(b).  
Region Residue (approximate range) 
Switch I 25-40 
Switch II 60-75 
L7 104-111 
L8 118-127 
L10 148-155 
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Table 4.1: Secondary structural element of Ras with corresponding residue numbers. These 
serve as a reference for different structural regions on Ras mentioned in this study.  
 
 
DCCM analysis of the entire trajectory suggests that several transitions have occurred in H-
ras, involving changes in loops at lobe II and increased correlated motion between lobes I 
and II. The increased dynamics at L8 and L10 of H-ras appears to be correlated with a series 
of regions across the entire protein. These coupled motions are greatly reduced in K-ras 
(Figure 4.2). The change in RMSD of L10 seems to be related to fluctuation in the switch I 
regions for both H-ras and K-ras (Figure 4.3 (a) and 4.5). Interestingly L10 RMSD for H-ras 
is almost twice that of K-ras and T35S.  The plot of conformers colored by cluster clearly 
shows that the displacement of L10 involves major conformational change in H-ras. This 
may suggest a specific role for key residues on the loops of lobe II for differential dynamics 
between H-ras and K-ras.  
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Figure 4.2: DCCM plots of H-ras (upper triangle) and K-ras (lower triangle) Cα atoms. Red 
circles highlight correlated motions previously described. 
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Figure 4.3 : Cα RMSD of residues 144-153 (a). PCA projection of conformers for H-ras (b) 
and K-ras (c) are colored according to their RMSD clusters. Inset shows PCA projections 
colored by density. 
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4.2. Comparison of state I/ State II populations of H-ras and K-ras  
A distance plot (see section 3.3) was utilized to differentiate between states I and II as well as 
among intermediate states. We observe that K-ras is more dynamic than H-ras at switch I 
where there is a direct transition to a state I-like intermediate as T35 loses coordination with 
the Mg
2+
 ion and switch I opens at T35 (Figure 4.4). This is consistent with NMR studies that 
report a slightly higher probability of K-ras to sample state I conformations [25,28].  The 
Y32-G12(Cα) plot suggests that this region of switch I is more flexible in K-ras and has a 
different conformation from H-ras. This is indeed the case as previously mentioned (see 4.2). 
Similarly, T35S H-ras adopts a more open switch I conformation than H-ras, with two 
distinct populations. However the S35-G12 (Cα) distance of cluster 1 (~150-300ns) 
correlates well with the crystal structure reported for T35S in a state I intermediate 
conformation termed state I /form II. [29]. The Y32-G12 (Cα) distance for T35S mutant is 
similar to H-ras WT, which is also characteristic of T35S state I/form II. In contrast the T35A 
mutant has a strong deviation at switch I, especially at residues 35 and 32, indicating an 
almost entirely state I population, in agreement with NMR data [26,28]. 
 
Figure 4.4: Distance between Cα atoms of residue T35 and G12 (a). Distance between Cα 
atoms of residue Y32 and G12 (b).  
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4.3 Conformational clusters identified by the first few PCs highlight specific structural 
differences between conformers.  
To define specific conformational clusters, a dissimilarity matrix was prepared for 
hierarchical clustering using either the first 4 PC’s or the pairwise RMSD of all Cα atoms.  
The PC derived clusters  are representive of conformers that differ primarily due to the 
switch dynamics for K-ras and L10 dynamics for H-ras (Figure 4.5). However a comparison 
of RMSD derived clusters shows that it coincdes with the T35-G12(Cα) distance for the 
proteins (Figure 4.5). A comparison of the two methods clearly show that the PC method is 
more sensitive to conformational differences since these clusters are also dependent on 
switch II.  We therefore concluded that PC based clustering provides a more refined method 
of clustering to discriminate between conformers
11
. However as previously desribed, plotting 
the T35-G12 Cα distance can be useful in categorizing state I/II intermediates, therefore we 
have used the RMSD clusters for further analysis of state II intermediates.   
                                                          
11
  For each system the same number of clusters was selected for both the PC and RMSD method. 
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Figure 4.5: RMSD of Cα atoms of switch I (black) and switch II (blue) for H-ras (a) and K-
ras (b). Colored bars represent different conformational clusters based on PC (top) and 
RMSD (below). Different colors represent different conformational clusters as defined by the 
PC or RMSD, however the colors are simply to highlight clusters and their magnitude 
accoridng to their sampling during the simulation. 
 
Projection of MD conformers reveals distinct conformational populations for Ras 
isoforms. 
In order to visualize MD conformers in relation to the crystal conformers we used a 
projection tool which utilizes the mean and the PCA loadings values from the crystal 
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conformer data set to calculate the variance. Hence these conformers can be projected onto 
the PC’s defined by the crystal data set. Accordingly the conformations are represented based 
on their variance from the crystal structures according to the PCs.  An initial inspection of the 
projected conformers reveals that the MD conformers are very dynamic and sample a large 
region of PC space along the first two principal components. Since switch I and II dictates 
most of the variance of the first few PCs amongst the X-ray structures, projection onto PC 1 
and PC 2 essentially describes the conformers based on their similarity at the switch regions.  
The conformer plot of T35A H-ras clearly shows that it is very dynamic and samples a region 
of conformational space in terms of both PC 1 and PC 2.  Furthermore there are distinct 
conformational clusters for the wild type isoforms. The difference is even more evident 
between the Q61H mutants of H- and K-ras. The T35S mutant and WT K-ras both have two 
distinct clusters, which are representative of the large deviation of switch I in both these 
systems.   
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Figure 4.6: Distribution of Ras MD conformers in PC space with blue points representing 
MD conformers and lack dots crystal conformers. a-e; H-ras (wt), Q61H-H-ras, T35S-H-ras, 
K-ras (wt), Q61H-K-ras, T35A-H-ras. 
 
Analysis of conformational clusters reveals similar dynamics for K-ras and the T35S 
mutant. 
Dynamic cross correlation analysis of the major K-ras and H-ras clusters show that there are 
altered correlated motions between the two isoforms. A closer look at the residue correlations 
(fig 4.7 (a)) reveals that more residues are involved in correlated motions between switch II 
and III (1)
12
 in K-ras than H-ras. Correlation is also observed between switch I and the α 
helix of switch II (3). Lastly the correlation between the C-terminus and β2-L3-β3 (2) is 
present throughout the K-ras simulation but is significantly reduced in H-ras. This may 
indicate a communication pathway between lobes I and II that is always present in K-ras but 
                                                          
12
 These are labeled on Figure 4.5 for easy reference. 
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only appears during transitions in H-ras [59]. Furthermore we observe that  H-ras has 
comparable dynamics to previous results obtained from accelerated molecular dynamics 
simulations of H-ras.[59]. T35S H-ras displays correlated motions more comparable with K-
ras. Correlations between switch I and II and between β2 and β3 are maintained in K-ras and 
T35S H-ras, however there is increased correlation between helices III and IV for T35S. 
Additionally correlation between residues 40 and 25 is not observed in T35S and K-ras but is 
present in H-ras and T35A. For T35A H-ras the correlation between α helices III and II is 
weakened, which is similar to the GDP state of H-ras [59]. Additionally there is anti-
correlation between the P-loop and switch II, suggesting a possible role of these regions in 
the association with effectors.  
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Figure 4.7: Dynamic cross correlation map of major RMSD clusters of H-ras (upper 
triangle) and K-ras  (lower triangle) (top) and T35SA (upper triangle) and T35S (lower 
triangle (bottom). 
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To further investigate the dynamics that may affect the correlated motions within 
conformational clusters we looked at RMSF’s of each system relative to H-ras. Figure 4.8 (a) 
shows the ΔRMSF for K-ras and T35S while Figure 4.8 (b) compares T35S to T35A. We 
observe that helix I of K-ras and T35S is more rigid but there are increased dynamics at the 
switch I loop. We also notice a decrease in the dynamics of switch II and also L8. Both K-ras 
and T35S are more dynamic at L10 and L7 particularly residue 107. However there is an 
increase in flexibility at helix III in T35S H-ras, which may account for the increased 
communication between α helices III and IV mentioned earlier. Additionally both K-ras and 
T35S have decreased dynamics at β2-L3-β3 (residues 40-50), which may account for 
correlations observed with the C-terminus that is absent in H-ras. The comparison of T35S to 
T35A reveals increased dynamics at the switches for T35A. Since the T35A mutant shares 
similar dynamics to H-ras at residues 107 and L8, which differ for T35S and K-ras, we 
certainly realize the implications of these specific residues in altering the conformational 
dynamics between isoforms, hence affecting effector interactions. 
 
 
Figure 4.8 RMSF difference plots between major cluster (ΔRMSF) from H-ras (top) T35A 
(bottom). Switch regions are highlighted and dotted red lines highlight residues in L7, L8 and 
L10. 
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4.4 Dynamics of Ras Q61H Mutants 
 
To access the effects of specific mutations on Ras isoforms we studied the dynamics of the 
Q61H mutants of H-ras and K-ras, from here on Q61H-H and Q61H-K. There are distinct 
conformational populations for these mutants (Figure 4.5). Additionally cluster analysis 
reveals two conformational clusters of Q61H-H, which differ in the switch I region. In this 
case switch I opens at Q61H-H resulting in state I intermediate conformations (Figure 4.9). 
Conversely Q61H-K adopts a large conformational cluster, which is less flexible at switch II, 
and does not sample state I (Figure 4.10).  
 
 
 
Figure 4.9: PC plot of Q61H –H-ras (a) Inset: density colored projection. Overlay of 
backbone conformations of the major clusters C1 and C2. (b) 
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Figure 4.10: PC plot of Q61H –K (a) Inset; density colored projection. Overlay of backbone 
conformations of the major clusters C1 and C2. (b) RMSF of clusters 1 and 2 for Q61H K-
ras. 
 
For further analysis we describe the dynamics of the major clusters for the Q61H mutants.  
Interestingly Q61H-K is more similar to H-ras in terms of correlated motions and dynamics. 
Firstly DCCM analysis shows a correlated motion between residues 40 and 25 and also 
between helix III and L8 on Q61H-K but not Q61H-H (Figure 4.11). Q61H-H retains 
flexibility at L10 similar to H-ras, however Q61H-K has altered dynamics compared to K-
ras. For example there is an increase in flexibility at L8 and decreased flexibility at L7. In 
comparison Q61H-K is more dynamic at switch II than Q61H-H, which samples State I-like 
conformations. This may provide critical clues into the isoform specific oncogenic potential 
of certain mutants; in particular Q61H-H may have oncogenic potential via rapid cycling 
through state I/II conformations. Meanwhile the same mutations may affect K-ras differently 
since increased dynamics of switch II may hinder its ability to associate with GAPs [18,101]. 
Additionally this may also affect the interaction with effectors and GEF’s that interact with 
switch II, hence decreasing the oncogenic potential of Q61H-K. NMR studies on Ras 
mutants showed an increase in GAP hydrolysis upon selection of state II [25] and the Q61L 
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H-ras mutant is susceptible to GAP mediated GTP hydrolysis whereas the H-ras G12V 
mutant is not [102]. We therefore gain critical insights into the conformational dynamics of 
these mutant isoforms that may explain the difference in oncogenic potential observed for 
specific isoforms of Ras mutants.  
 
 
 
 
                                
 
Figure 4.11: Dynamic cross correlational analysis over Q61H H-ras and K-ras mutants (a) 
RMSF difference plots between major cluster  (Δ RMSF)  from H-ras (b)  
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Discussion 
Based on our conformational analysis of the protein backbone we have shown that K-ras and 
T35S H-ras mutants are similar in their dynamics and correlated motions.  For T35S the 
increase in the dynamics of residues Y64 and D63, which  are crucial for associating with 
PI3K [15], may partially explain the loss of specificity to PI3K since these residues are 
involved in the interaction of Ras with PI3K.  
Mutations in the switch II region of Ras have been shown to perturb interactions with various 
effectors [103]. In our analysis of the backbone H-ras and K-ras display very different 
dynamics in the switch II region. On the other hand K-ras is more dynamic than H-ras at 
switch I, which may explain the preferential interaction of H-ras with Raf-RBD [46]. The 
stability of switch II in K-ras may be a factor in the preferential activation of Raf by K-ras, 
since switch II interaction with the cysteine rich domain of Raf is necessary for its activation 
[104,105]. Stabilization of switch II on K-ras may also affect its affinity for specific GEF’s, 
effectors and calmodulin since switch II residues are involved in these interactions 
[48,106,107]. Additionally, previous molecular dynamics simulations on the Ras–Raf 
complex of H-ras showed a decrease in the dynamics of switch I/II, β1 and L7 regions upon 
complex formation [108].  
A role for increased dynamics on lobe II 
Another important observation is the reduced flexibility of L8 on K-ras in a similar manner 
to that of T35S H-ras.  Loop 8 (residues 119-125) adjoins the amphipathic helix IV, which 
contacts the membrane. Decreased flexibility at this region may affect the membrane 
interactions.  Usually the substitution of any residue for proline renders rigidity in the protein 
backbone since its side chain is part of the backbone [109]. Hence the A122P substitution on 
53 
 
K-ras could stabilize this loop and may contribute to the increased dynamics and transition to 
a state I intermediate of K-ras previously reported [25,94]. However we would like to note 
both K-ras and H-ras display enhanced dynamics at different regions. In particular, K-ras is 
more dynamic at switch I whereas H-ras is considerably more dynamic in lobe II. These 
differential motions in lobe II, specifically L10-Helix IV residues, are correlated with major 
conformational changes in the effector loop (switch I) of the systems studied. Consequently 
the dynamics of this region may also influence the orientation of Ras proteins on the 
membrane, since these residues are located towards the C-terminus and anchor of the protein. 
Overall we have determined that the correlation and flexibility between lobes I and II is very 
different for H and K-ras and affects the conformations of the effector binding loop more 
significantly in H-ras than K-ras.  
Specific mutations affect the conformational distribution between Ras isoforms 
Furthermore the Q61H point mutation alters the conformational distribution of K-ras and H-
ras differently. The same mutation leads to state I intermediate conformations in H-ras but 
not K-ras. This could partially explain why somatic Q61 H-ras mutants are found more 
frequently in H-ras related cancers than in those of K-ras [50], and is consistent with NMR 
studies that have shown that mutants which have oncogenic potential and low GTPase 
activity tend to adopt state I like conformations [28]. 
To conclude we have shown that the substitution of various amino acids on lobe II of H-ras 
and K-ras results in differential dynamics between these proteins. Interestingly the T35S 
point mutation on H-ras results in conformers that more resemble K-ras. Lastly the Q61H 
point mutation results in distinct conformational populations. In this case the H-ras mutant 
sampled state I-like conformations while the K-ras mutant sampled state II. 
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The role of specific residue interactions that affect the conformational dynamics will be 
discussed in Chapter 5.  
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CHAPTER 5 
The role of Specific Residue Interactions between Ras isoforms 
Overview 
X-ray crystallography and NMR studies of Ras in complex with various effectors and 
modulators  have identified key elements on the effector binding loop and the switch II 
region that are necessary for the Ras-effector/modulator association[15,17,18,19,21,61]. 
Although, the RBDs of the Ras effectors Raf, PI3K and Ral have very little sequence 
homology they have substantial structural similarities in their RBD [110]. The specificity of 
Ras isoforms towards the effectors Raf and PI3K [37] suggests that the effector binding loop 
of Ras may achieve specificity through sampling various conformations. Therefore, different 
conformations may permit specific association with effector/modulator proteins through 
differences in the dynamics and through the rearrangements of specific residues. In Chapter 4 
we have investigated the conformational dynamics within conformational sub-states of H-ras 
and K-ras isoforms and specific mutants. In this chapter we will explore the specific side 
chain contributions to the dynamics and overall conformation in terms of salt bridges, 
hydrogen bonds and hydrophobic contacts.  First we will investigate the unique contacts in 
K-ras and H-ras and compare them to those in T35S H-ras (T35S). We then investigate the 
conformations of Q61H mutants to probe for specific contacts that may explain the 
differential conformational dynamics previously described between the H and K-ras isoforms 
of this mutant. 
5.1 K-ras and T35S H-ras are similar in terms of their side chain interactions  
We have utilized the contact map described in Chapter 2 to find contacts that are unique for 
each conformational cluster of our system. First contacts were determined for each system in 
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terms of occupancy (% contacts) within the conformational cluster and then subtracted from 
those made in H-ras. Only contacts that were unique and had at least 50 % occupancy were 
considered for analysis. An inspection of the global contacts unique for K-ras and T35S 
reveals that they share similarities in the residue interaction profile (Figure 5.1). The T35S 
simulation  was started from the crystal structure (3KKN) [98] in a state I conformation and 
it sampled a wide region of conformational space, however we have selected a cluster 
reminiscent of state I form II for analysis. The similarity of this mutant in terms of 
conformational dynamics to K-ras is quite striking, considering that T35S is a point mutation 
on switch II, whereas K-ras differs from H-ras in terms of several residues on lobe II.  
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Figure 5.1: Time averaged residue contacts in H-ras, K-ras and T35S-Hras clusters. Color 
Bars represent the occupancy of the contact and unique contacts for either K-ras vs H-ras 
(upper triangle) or (T35S vs H-ras). H-ras specific contacts are colored yellow to red, K-ras 
cyan to blue and T35S grey to black. A contact is described as any two side chain residues 
within 4Å of each other. 
Absence of Y71–E37 and E37-A59 H-bonds in T35S-H-ras and K-ras may explain their 
similar dynamics 
There are frequent contacts between switches I and II that appear to be unique for H-ras 
(Figure 5.1). This is actually due to the presence of a H-bond between the Y71 OH and the 
acidic oxygen on E37 that is almost absent in K-ras and T35S. This contact is replaced by a 
H-bond between A59 N and Y71OH on K-ras and T35S (fig 5.2). The replacement of a 
threonine with serine disrupts the hydrogen bonds between the I36 O and A59 N in T35S H-
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ras, which also affects the E37-Y71 H-bond. Interestingly the I36-A59 H-bond is also broken 
in K-ras. Since residues I36 and E37 have been shown to interact with both PI3K and Raf 
[15,20], differential contacts in this region may  result in different preference for effectors. 
 
    
Figure 5. 2:  Hydrogen bonds represented by distance between the donor and acceptor atoms 
for H-ras(orange), T35S(grey) and K-ras(blue). (a) I36-A59 H-bond, (b) E37-Y71 H-bond, 
(c) A59-Y71 H bond (d) H-bonds unique to H-ras are represented by black dotted lines and 
for  K-ras and T35S red dotted lines.  
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Switch I residues D38 and E37  
There is an increase in distance between residues D38 and D33 in K-ras and T35S due to 
reorientation of the side chain of D38 (Figure 5.4). This may be due to above mentioned 
rearrangement of H-bonds between residues 37 and 71. The reorientation of residue 38 may 
also play a role in altering the negatively charged groove formed by D33-D38, which is 
important for favorable interaction with a lysine on the α helix 1 of effectors and β2 of 
NORE1 [107]. Another putative role of the reorientation of residue 38 is the specificity of the 
association with PI3K since the D38E mutant retains its ability to associate with Raf and not 
PI3K while the E37G mutant will only associate with Ral-GDS [47]. The reorientation of 
residue 38 in K-ras and T35S coupled with the sensitivity of the D38E mutant to PI3K and 
E37G to RalGDS suggests that these residues may play a role in fine tuning the Ras affinity 
for specific effectors. Furthermore, since NORE1 interacts with switch I through a lysine on 
its β2 strand, instead of α helix 1 present in other effectors, this interaction may be more 
favorable for K-ras where D38 is oriented outwards. We also observe different orientations 
of effector binding residues Q25 and N26 which are involved in hydrogen bonds in the Raf-
Rap complex [61] . 
Specific switch II contacts: a role for Y64 
In K-ras we observe a reorientation of Y64 as it forms a stable hydrogen bond with D69 
(Figure 5.3). Residue 64 plays a crucial role in interaction with effectors where it associates 
with a phenylalanine on the β1 strand of NORE1 [107]. In addition Y64 and Y71 form 
contacts with SOS [17]. The reorientation of this Y71 and its H-bond with D69 may therefore 
alter the preference of Ras for these effectors. This can in part explain the reduced affinity of 
K-ras to PI3K and SOS. Since the G12V/Y64G mutant is Raf-specific we may presume that 
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Y64 may be dispensable for Raf activation. However the Y64W mutation abolishes binding 
to the Raf CRD [105], thus there may be a specific role for the orientation of this residue 
since the bulky side chain  and lack of an OH in Tryptophan may hinder interactions with 
Raf-CRD. 
 
 
 
Figure 5.3 H-bond between Y64 OH and D69 O (a). Orientation of specific residues on H-
ras (orange), K-ras (blue) and T35S (grey) (b) 
 
A D119-K147 salt bridge stabilizes L8 and L10 in K-ras and T35S 
Residues 116-119 and 145-147 are part of the consensus guanine nucleotide base binding site 
on GTPases [111]. Interestingly monoubiquitination of K-ras at residue 147 increases its 
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GTP loading and enhances the affinity of K-ras G12V to PI3K and Raf but does not affect its 
localization in the membrane[112]. Ras isoforms have different ubiquitination sites: 104 and 
147 on K-ras and 117, 147 and 170 on H-ras [112].  The two major ubiquitination sites are 
K117 and K147  on loops 8 and 10 respectively [112]. A salt bridge is formed between K147 
and D119 (Illustrated in Figure 5.4 (d)). This contact is more frequent in K-ras and T35S (see 
Figure 5.1) which may account for the reduced flexibility of at L8. Previous molecular 
dynamics studies on the ubiquitination of proteins have proposed that the role of ubiquination 
is more of conformational restriction [113], hence we may speculate that  ubiquination of 
K147 may alter the dynamics of K-ras via affecting the D119-K147 salt bridge to  select 
conformations more favorable for effector interactions with PI3K.  
Specific roles of other residue contacts 
An decrease in contacts between the P-loop and switch II in T35S is due to the loss of the 
G12 N and G60 O H-bond. The G60A mutation moderately decreases the binding of H-ras to 
Raf RBD while significantly reducing the binding  to RalGDS [114]. Likewise the T35S 
mutant also has decreased affinity to RalGDS [47], which specifies  an involvement of the 
G60-G12 H-bond in stabilizing Ras conformations that associate with specific effectors.  
Residue 27, which also interacts with Raf (Figure 5.4 (b)), adopts a conformation towards the 
guanine base of GTP and the P-loop in K-ras. The crystal structures of H-ras∙GTP and H-
ras∙GDP (pdb id 1QRA and 4Q21) clearly show that H27 adopts a different orientation with 
respect to the guanine nucleotide and K147 in the GTP and GDP state. The reorientation of 
H27  between H-ras GTP and H-ras GDP conformations, suggests that in H-ras this residue 
may play a role in conformational sensitivity to the nucleotide , which may in part affect the 
orientation of H-ras in the membrane due to the presence of GTP or GDP. However, since in 
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K-ras and T35S H-ras the orientation of H27 resembles H-ras GDP, the conformational 
sensitivity and ability to affect membrane orientation may be reduced or absent.  
 
 
Figure 5.4 (a) Distance of H27 CE1-G12 CA in Hras (orange), K-ras(blue) and T35S(black). 
(b) Residue specific contacts of Rap-Raf complex with Rap in red and Raf in blue. (c) Side 
chain reorientation of H27, K147 and N26. (d) Salt bridge between K147 and D119 on K-ras 
and T35S crystal structures of H-ras∙GTP (red) and H-ras∙GDP (green) showing orientation 
of H27 with respect to K147 and the nucleotide.  
 
5.2 Residue interactions in K-ras Q61H are similar to WT H-ras.  
Previously we noted that the Q61H mutation perturbs the conformational equilibrium 
differently for H-ras and K-ras. Here we compared the overall dynamics of the WT isoforms 
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to the Q61H mutants. Q61H K-ras has a similar residue contact profile to WT H-ras (Figure 
5.5). Firstly the H-bond between residue Y71 and E37 and G60- G12 is maintained in the 
Q61H K-ras mutant but not the H-ras mutant. The loss of these contacts appears to be 
coupled with the gain of the A59- Y71 H-bond on Q61H H-ras. Furthermore a unique salt 
bridge is formed between residues on helix III and II on Q61H-Hras (Figure 5.6). Since 
mutations at position 61 in H-ras are more frequently found in cancers compared to K-
ras[50], one may reason that this mutation is more oncogenic in H-ras.  In addition the 
similar contacts with T35S and WT K-ras suggest that it may potentially activate Raf better 
than Q61H K-ras. However, there is no current literature on the potential of these mutant 
isoforms to activate Raf.  Although Q61H H-ras more readily adopts state I-like 
conformations in comparison to Q61H K-ras (Figure 5.6 (b)), oncogenic potential may also 
be achieved by rapidly cycling between state I and state II.  
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Figure 5.5:  Time averaged residue contacts Q61H-Hras and Q61H K-ras simulations. Q61H 
K-ras contacts are subtracted from Q61H H-ras (upper triangle) and K-ras from H-ras (lower 
triangle). Contacts unique to H-ras/Q61H H-ras are colored yellow to orange based on 
occupancy and cyan to blue for K-ras/Q61H K-ras. A contact is described as any two side 
chain residues within 4Å of each other. 
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Figure 5.6: Secondary structure of Q61H H-ras and K-ras conformers (blue and yellow) 
respectively (a). Salt bridge between R102 and D69. 
 
Stabilization of the switch II helix in K-ras 
From our simulations, we mutated residue H61 on the Q61H mutant back to the WT. This 
change resulted in very different conformations of K-ras and the Q61H K-ras mutant. 
Interestingly it appears that the H61 may affect the switch II architecture in K-ras, by 
affecting the Y64-D69 H- bond. Furthermore we also note that the switch II helix forms an 
alpha helix in the wild type and a pi helix on the Q61H mutant K-ras.  
 
 
Figure 5.7: Switch II K-ras (cyan) and Q61H K-ras (blue) 
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Discussion:  
 In the previous chapter we have observed that in our simulations the T35S H-ras mutation 
results in a population of conformational sub-states that are similar to K-ras in dynamics; 
however the aim of this chapter was to investigate the conformation in terms of their residue 
contacts and side chain reorientations, which may affect or be affected by differential 
dynamics. We observe that T35S H-ras also has residue contacts that are similar to K-ras. To 
reiterate the loss of an H-bond on switch I residues I36 and A59 as well as on E37 and Y71 
results in a A59-Y71 H-bond which propagates across the structure and results in 
conformations that are more similar to K-ras. These structural and residue rearrangements on 
T35S and K-ras that differ from WT H-ras suggest that they are involved in conferring a 
degree of conformational specificity for either favorable association with Raf or reduced 
affinity for PI3K. Furthermore the specific differences in residue contacts and orientations 
between Kras and H-ras at the switch regions, especially switch II, may influence effector 
specificity. Our primary reason for this assertion is because most effectors and modulators 
that have specificity for a particular Ras isoform, i.e NORE1, SOS, Ras-GRF, PI3K and Raf 
CRD and calmodulin, interact with the switch II of Ras [17,48,105,106,107]. Furthermore we 
have seen that the Q61H mutation drastically affects the conformational population towards 
state I on H-ras similar to the T35S substitution whereas the Q61H K-ras mutant more 
resembles H-ras WT in terms of dynamics and residue interactions. The differential effect of 
the mutation at position 61 may partially explain the prevalence of Hras Q61 mutant in 
cancers compared to mutants of Q61 K-ras mutants.  
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Summary and Outlook 
Summary 
There has been overwhelming evidence which shows Ras isoforms have non-redundant roles 
in the cell (reviewed in [45]). The aim of this study was to characterize the catalytic domain 
of H-ras and K-ras in terms of dynamics. We have shown that H-ras and K-ras differ in 
dynamics when bound to GTP and Mg
2+
. The isoforms differ in flexibility at regions where 
there is sequence variation in lobe II as well as in the conserved, functionally important 
switch regions in lobe I.  
This analysis has provided insights into a possible role of the H-ras and K-ras catalytic 
domain in their ability to recognize effectors in a specific manner.  Our molecular dynamics 
simulations have resulted in two very distinct populations of H-ras and K-ras conformers that 
differ both in dynamics and conformation. In addition the simulations shows that K-ras is 
more dynamic than H-ras and has a higher tendency to a adopt state I populations within the 
time frame of the simulations. Moreover, conformer analysis revealed that the Raf-selective 
T35S H-ras mutant shares similarity with K-ras in terms of both dynamics and the side chain 
orientation of key effector/modulator binding residues at the switch regions. For instance, the 
switch I region of T35S H-ras resembles K-ras rather than H-ras. The conformational 
similarity between this mutant and K-ras provided us with a new view of dynamics that may 
enhance Raf activation, whereas the comparison between K-ras and H-ras provided new 
insights into some of the crucial elements for selective PI3K associations. Our data suggest 
that although H-ras has a higher affinity for Raf [46], which contacts Raf at the effector 
binding switch I [20], the switch II region of K-ras is so different in dynamics and side chain 
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orientations it partially explains the ability of K-ras to better activate Raf, since effective Raf 
activation involves the interaction of the switch II of Ras with the CRD of Raf [105]. We 
therefore conclude that H-ras and K-ras adopt different conformational populations and that 
K-ras fluctuates around a conformation that is more favorable for Raf association and not 
PI3K.  
The implications of the variations in dynamics may be extended to differential orientation of 
the catalytic domain on the membrane surface since there is considerable flexibility in L8 of 
H-ras which adjoins the amphipathic α helix 4, which associates with membrane [115]. This 
is critical since studies have also shown that the nature of the bound nucleotide affects the 
membrane orientation of H-ras [115,116]. The relative rigidity of K-ras at L8 can potentially 
hinder its ability to reorient in the membrane. Furthermore, increased correlated motions 
between lobes II and I in H-ras may suggest that there is increased communication across the 
lobes so that lobe II of H-ras may be more sensitive to the nature of the bound nucleotide. 
Furthermore specific Ras mutations alter the conformational distribution of H-ras and K-ras, 
with the Q61H mutation in H-ras but not K-ras resulting in state I-like sub states. This is an 
interesting finding since genomic studies have shown that the specific point mutation of Q61 
appears to be both cell and isoform specific, with the H-ras mutations appearing to have a 
higher occurrence in tumors than those of K-ras [50]. This could be due to rapid cycling 
between state I and state II since state I Ras has low affinity for GAPs and high affinity for 
GEFs, resulting in faster nucleotide exchange [102]. Therefore the rapid cycling could result 
in a partially constitutively active protein with an oncogenic potential.  
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Implications of the work for translational studies  
This work provides crucial structural information for isoform selective drug design to disrupt 
aberrant Ras signaling.  Biochemical studies have shown that Ras mutants may alter the 
preference of Ras isoforms for different effectors and perturb the conformational equilibra 
between states I and II [25,26,28]. Additionally the occurrence of point mutations on Ras 
isoforms is variable and varies in frequency amongst different cancers and developmental 
diseases [24,50,102]. These results highlight the need to reassess the specificities of aberrant 
Ras signaling due to specific point mutations across isoforms. As we can clearly see we have 
identified distinct conformations of H-ras and K-ras and their Q61H mutants. The 
conformational analysis presented here highlights the usefulness of molecular dynamics to 
assess multiple conformations of the catalytic for drug discovery. Due to the high structural 
similarity among Ras GTPases, it has often been thought that targeting the catalytic domain 
may lead to many off target effects. Our results indicate that there are specific features 
between Ras isoforms, highlighting the need to study the dynamics of other members of the 
Ras family for targeted drug design. We propose that using molecular dynamics to access 
conformational sub states in members of a protein family can yield conformational 
ensembles and transient structures not revealed by other methods. Combining molecular 
dynamics with PCA can provide a manageable set of conformers and defined conformational 
clusters for docking. 
Further studies: Enhanced conformational Sampling  
A limitation of classical molecular dynamics simulation is the inability to sample all 
accessible conformations. To further determine the conformational sub-states not revealed by 
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our simulations, an enhanced sampling method such as accelerated molecular dynamics 
(aMD) may be used. Furthermore, utilization of the molecular mechanics/generalized Born 
surface area (MM-GBSA) methods [117,118] or thermodynamic integration [119]  may be 
useful to characterize energetic barriers between conformations.  Another area of interest is 
the dynamics of Ras-Raf complexes made by different Ras isoforms. Much analysis has been 
carried out on the structural dynamics of the Ras- Raf complex but these were limited to H-
ras. The difference in dynamics we observed between H-ras and K-ras suggests that these 
data are not sufficient to explain K-ras/effector interactions. Hence, a further application of 
this work lies in addressing the conformational specificities and dynamics of isoform specific 
effector interactions. Finally, we mentioned above the possible effect of differential 
dynamics in the membrane orientation of nucleotide bound Ras. A comparative all-atom 
molecular dynamics simulations of membrane bound full length H-ras[115] and K-ras in both 
the GTP and GDP forms would be interesting.  
In closing we have accessed the contributions of specific residue differences on lobe II of K-
ras and H-ras and have discovered key differences in dynamics that alter the conformations at 
the functionally important switch regions. These differential dynamics may also alter the 
conformational properties of membrane bound Ras. This work shows that a general 
reassessment of Ras isoforms needs to be made since sequence differences may have a 
significant impact on conformational dynamics.  
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